Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

Blood (2023) 142 (Supplement 1): 635.

https://doi.org/10.1182/blood-2023-173709

Published: 2023

Journal Articles

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Christoph Kornauth, Tea Pemovska, PhDMSc,BSc, Gregory Ian Vladimer, PhD, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Harald Esterbauer, MD PhD, Ruth Exner, Verena Felsleitner-Hauer, Maurizio Forte, MSc, Alexander Gaiger, Hildegard T. Greinix, MD, Wolfgang Gstöttner, Marcus Hacker, Alexander Hauswirth, MD, Tim Heinemann, Daniel Heintel, Mir Ali Reza Hoda, Ulrich Jaeger, Lukas Kazianka, MD, Lukas Kenner, MD, Barbara Kiesewetter, MD, Nikolaus Krall, PhD, Trang Le, BSc, Simone Lubowitzki, Marius E Mayerhoefer, Elisabeth Menschel, Olaf Merkel, PhD, Katsuhiro Miura, MD PhD, Leonhard Muellauer, MD PhD, Peter Neumeister, MD, Thomas Noesslinger, MD, Katharina Ocko, Leopold Öhler, Michael Panny, MD, Alexander Pichler, MD, Edit Anna Porpaczy, MD, Gerald Prager, MD, Markus Raderer, Robin Ristl, Reinhard Ruckser, MD, Julius Salamon, Ana-Iris Schiefer, Ann-Sofie Schmolke, MD, Ilse Schwarzinger, MD, Edgar Selzer, Cathrin Skrabs, Wolfgang R. Sperr, MD, Ismet Srndic, MSc, Renate Thalhammer, MD, Peter Valent, MD, Emiel van der Kouwe, PharmD, Katrina Vanura, PhD, Stefan Vogt, Cora Waldstein, Dominik Wolf, Univ. Prof. Dr., Christoph Zielinski, Ingrid Simonitsch-Klupp, MD, Giulio Superti-Furga, PhD, Berend Snijder, PhD, Philipp B. Staber, MD PhD

Blood (2020) 136 (Supplement 1): 2–4.

https://doi.org/10.1182/blood-2020-140831

Published: 2020

Journal Articles

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Heinz Ludwig, Univ. Prof. Dr., Elisabeth Rauch, Thomas Kuehr, MD, Adam Zdenek, MD, Adalbert Weissmann, MD, Hedwig Kasparu, MD, Eva-Maria Autzinger, MD, Daniel Heintel, MD, Richard Greil, MD, Wolfram Poenisch, MD, Niklas Zojer, MD, Ercan Müldür, MD

Blood (2014) 124 (21): 3484.

https://doi.org/10.1182/blood.V124.21.3484.3484

Published: 2014

Journal Articles

Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Is Downregulated in Multiple Myeloma with Consequneces for Myeloma Cell Growth and Bone Disease

Arnold Bolomsky, Dirk Hose, MD, Martin Schreder, MD, Anja Seckinger, MD, Tobias Meißner, Bernard Klein, Daniel Heintel, Sabine Pfeifer, Heinz Ludwig, Niklas Zojer

Blood (2012) 120 (21): 3947.

https://doi.org/10.1182/blood.V120.21.3947.3947

Published: 2012

Journal Articles

Significant Activity of Lenalidomide-Dexamethasone in Multiple Myeloma (MM) Patients with Light Chain Induced Acute Renal Failure (LC-ARF)

Heinz Ludwig, Elisabeth Rauch, Thomas Kuhr, Adalbert Weissman, Daniel Heintel, Niklas Zojer, Hedwig Kasparu, Richard Greil, MD, Zdenek Adam

Blood (2012) 120 (21): 4031.

https://doi.org/10.1182/blood.V120.21.4031.4031

Published: 2012

Journal Articles

Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians

Heinz Ludwig, MD, Hedwig Kasparu, Werner Linkesch, MD, Josef Thaler, Richard Greil, MD, Clemens Leitgeb, Daniel Heintel, Elisabeth Rauch, Niklas Zojer, Ludek Pour, Adelheid Seebacher, Zdenek Adam

Blood (2011) 118 (21): 2928.

https://doi.org/10.1182/blood.V118.21.2928.2928

Published: 2011

Journal Articles

High Expression of the Thalidomide-Binding Protein Cereblon (CRBN) Is Associated with Improved Clinical Response in Patients with Multiple Myeloma Treated with Lenalidomide and Dexamethasone

Daniel Heintel, Arnold Bolomsky, Martin Schreder, MD, Sabine Pfeifer, Niklas Zojer, Ulrich Jäger, Heinz Ludwig, MD

Blood (2011) 118 (21): 2879.

https://doi.org/10.1182/blood.V118.21.2879.2879

Published: 2011

Journal Articles

Identification of Genes Associated with Resistance and Response in Vivo to Therapy with Rituximab, Fludarabine and Cyclophosphamide in Patients with Chronic Lymphocytic Leukemia.

Blood (2008) 112 (11): 1622.

https://doi.org/10.1182/blood.V112.11.1622.1622

Published: 2008

Journal Articles

Gene Expression Signature of B-Cell Chronic Lymphocytic Leukemia with Trisomy 12.

Blood (2007) 110 (11): 2079.

https://doi.org/10.1182/blood.V110.11.2079.2079

Published: 2007

Journal Articles

Monokine Induced by Interferon-γ (MIG) Serum Levels Are a Marker of Disease Load and Correlate with Prognosis in Multiple Myeloma.

Martin Schreder, MD, Gudrun Koch, Daniel Heintel, MD, Kathrin Strasser-Weippl, MD, Katrin Frischmuth, MD, Ulrich Jaeger, MD, Heinz Ludwig, MD, Niklas Zojer, MD

Blood (2006) 108 (11): 5040.

https://doi.org/10.1182/blood.V108.11.5040.5040

Published: 2006

Journal Articles

The Paternally Expressed Gene 10 (PEG10) on Chromosome 7q21 Is Overexpressed and Imprinted in High-Risk B-CLL.

Blood (2005) 106 (11): 1221.

https://doi.org/10.1182/blood.V106.11.1221.1221

Published: 2005

Journal Articles

High Expression of MUM1/IRF4 mRNA Is Associated with a Shorter Overall Survival in Patients with Multiple Myeloma.

Daniel Heintel, MD, Niklas Zojer, MD, Kathrin Strasser-Weippl, MD, Michael Vesely, MD, Heinz Gisslinger, Johannes Drach, Alexander Gaiger, Ulrich Jäger, Heinz Ludwig

Blood (2005) 106 (11): 1550.

https://doi.org/10.1182/blood.V106.11.1550.1550

Published: 2005

Journal Articles

Prognostic Relevance of Lipoprotein Lipase (LPL) Expression in B-CLL.

Daniel Heintel, Dirk Kienle, Bilban Martin, Medhat Shehata, Alexander Kroeber, Dieter Mitteregger, Edith Porpaczy, Birgit Kainz, Michael Auer, Andreas Gleiss, Hartmut Dohner, Alexander Gaiger, Oswald Wagner, Stephan Stilgenbauer, Ulrich Jaeger

Blood (2004) 104 (11): 177.

https://doi.org/10.1182/blood.V104.11.177.177

Published: 2004

NARROW

First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Is Downregulated in Multiple Myeloma with Consequneces for Myeloma Cell Growth and Bone Disease

Significant Activity of Lenalidomide-Dexamethasone in Multiple Myeloma (MM) Patients with Light Chain Induced Acute Renal Failure (LC-ARF)

Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians

High Expression of the Thalidomide-Binding Protein Cereblon (CRBN) Is Associated with Improved Clinical Response in Patients with Multiple Myeloma Treated with Lenalidomide and Dexamethasone

Identification of Genes Associated with Resistance and Response in Vivo to Therapy with Rituximab, Fludarabine and Cyclophosphamide in Patients with Chronic Lymphocytic Leukemia.

Gene Expression Signature of B-Cell Chronic Lymphocytic Leukemia with Trisomy 12.

Monokine Induced by Interferon-γ (MIG) Serum Levels Are a Marker of Disease Load and Correlate with Prognosis in Multiple Myeloma.

The Paternally Expressed Gene 10 (PEG10) on Chromosome 7q21 Is Overexpressed and Imprinted in High-Risk B-CLL.

High Expression of MUM1/IRF4 mRNA Is Associated with a Shorter Overall Survival in Patients with Multiple Myeloma.

Prognostic Relevance of Lipoprotein Lipase (LPL) Expression in B-CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only